HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna-Maria Dieplinger Selected Research

COVID-19

1/2023Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors.
11/2022Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia.
5/2022Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna-Maria Dieplinger Research Topics

Disease

3COVID-19
01/2023 - 05/2022
2Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2023 - 02/2020
2Atrial Fibrillation
01/2023 - 01/2023
1Atrial Flutter (Flutter, Atrial)
01/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Heart Failure
01/2023
1Post-Acute COVID-19 Syndrome
11/2022
1Thrombosis (Thrombus)
05/2022
1Pulmonary Embolism
05/2022
1Stroke (Strokes)
05/2022
1Cardiac Arrhythmias (Arrythmia)
02/2020

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2020
1RivaroxabanIBA
01/2023
1omega-Chloroacetophenone (Mace)IBA
11/2022
1Proteins (Proteins, Gene)FDA Link
11/2022

Therapy/Procedure

3Therapeutics
01/2023 - 05/2022
1Critical Care (Surgical Intensive Care)
05/2022
1Artificial Respiration (Mechanical Ventilation)
05/2022